Beneficial and adverse effects of chemopreventive agents

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 523-524, Issue , 2003, Pages 265-278

  Lee, Byung Mu ^a   Park, Kwang Kyun ^b  

^a Sungkyunkwan University   (South Korea)

^b Yonsei University College of Dentistry   (South Korea)

Author keywords

Adverse effects; Carcinogenesis; Chemopreventive agents; Safety

Indexed keywords

3 INDOLEMETHANOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAPSAICIN; CARCINOGEN; ORGANOSULFUR DERIVATIVE; RETINOL; SELENIUM;

ALOE; CANCER; CANCER GROWTH; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON CANCER; CONFERENCE PAPER; GARLIC; HUMAN; LIVER CANCER; LUNG CANCER; PANCREAS CANCER; PREVENTION; PRIORITY JOURNAL; SMOKING; THYROID CANCER; TUMOR PROMOTION;

ALLIUM SATIVUM; ALOE;

EID: 0037294160     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00342-1     Document Type: Conference Paper

References (137)

1. Hecht S.S. Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention. Ann. N.Y. Acad. Sci. 833:1997;91-111.
2. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66:1981;1191-1308.
3. Sporn M.B., Suh N. Chemoprevention of cancer. Carcinogenesis. 21:2000;525-530.
4. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Malone W.A., Boone C.W., Kopelovich L., Hawk E.T., Lieberman R., Lawrence J.A., Ali I., Viner J.L., Sigman C.C. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. Suppl. 130:2000;467-471.
5. Reddy B.S. Micronutrients as chemopreventive agents. IARC Sci. Publ. 139:1996;221-235.
6. Wattenberg L.W. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res. (Suppl.). 52:1992;2085-2089.
7. Hong W.K., Sporn M.B. Recent advances in chemoprevention of cancer. Science. 278:1997;1073-1077.
8. Ferguson L.R. Antimutagens as cancer chemopreventive agents in the diet. Mut. Res. 307:1994;395-410.
9. De Flora S., Ramel C. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mut. Res. 202:1988;285-306.
10. Olson J.A. Vitamin A and carotenoids as antioxidants in a physiological context. J. Nutr. Sci. Vitaminol. Suppl. 39:1993;57-65.
11. Chang S.K., Harrington G.W., Rothstein M., Shergalis W.A., Swern D., Vohra S.K. Accelerating effect of ascorbic acid on N-nitrosamine formation and nitrosation by oxyhyponitrite. Cancer Res. 39:1979;3871-3874.
12. Schmahl D., Kruger F.W., Habs M., Diehl B. Influence of disulfiram on the organotropy of the carcinogenic effect of dimethylnitrosamine and diethylnitrosamine in rats. Z. Krebsforsch. Klin. Onkol. Cancer Res. Clin. Oncol. 85:1976;271-276.
13. Hennekens C.H., Stampfer M.J., Willett W. Micronutrients and cancer chemoprevention. Cancer Detect Prev. 7:1984;147-158.
14. Weisburger J.H. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am. J. Clin. Nutr. Suppl. 53:1991;226-237.
15. Woutersen R.A., Appel M.J., Van Garderen-Hoetmer A. Modulation of pancreatic carcinogenesis by antioxidants. Food Chem. Toxicol. 37:1999;981-984.
16. Peto R., Teppo L. Vitamin E and cancer prevention. Am. J. Clin. Nutr. (Suppl.). 53:1991;283-286.
17. Santamaria L., Bianchi A., Arnaboldi A., Ravetto C., Bianchi L., Pizzala R., Andreoni L., Santagati G., Bermond P. Chemoprevention of indirect and direct chemical carcinogenesis by carotenoids as oxygen radical quenchers. Ann. N.Y. Acad. Sci. 534:1988;584-596.
18. Krinsky N.I. Antioxidant functions of carotenoids. Free. Rad. Biol. Med. 7:1989;617-635.
19. Kelloff G.J., Crowell J.A., Boone C.W., Steele V.E., Lubet R.A., Greenwald P., Alberts D.S., Covey J.M., Doody L.A., Knapp G.G. Clinical development plan: beta-carotene and other carotenoids. J. Cell Biochem. Suppl. 20:1994;110-140.
20. Vainio H. Chemoprevention of cancer: a controversial and instructive story. Br. Med. Bull. 55:1999;500-593.
21. Moore S.R., Hill K.A., Heinmoller P.W., Halangoda A., Kunishige M., Buettner V.L., Graham K.S., Sommer S.S. Spontaneous mutation frequency and pattern in Big Blue mice fed a Vitamin E-supplemented diet. Environ. Mol. Mutagen. 34:1999;195-200.
22. Knekt P., Aromaa A., Maatela J., Aaran R.K., Nikkari T., Hakama M., Hakulinen T., Peto R., Teppo L. Vitamin E and cancer prevention. Am. J. Clin. Nutr. Suppl. 53:1991;283-286.
23. Factor V.M., Laskowska D., Jensen M.R., Woitach J.T., Popescu N.C., Thorgeirsson S.S. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2196-2201.
24. Lee B.M., Lee S.K., Kim H.S. Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (Vitamin E, Vitamin C, beta-carotene and red ginseng. Cancer Lett. 132:1998;219-227.
25. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group, The effect of Vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers, N. Engl. J. Med. 330 (1994) 1029-1035.
26. The ATBC Cancer Prevention Study Group, The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. The ATBC cancer prevention study group, Ann. Epidemiol. 4 (1994) 1-10.
27. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., Hartman A.M., Palmgren J., Freedman L.S., Haapakoski J., Barrett M.J., Pietinen P., Malila N., Tala E., Liippo K., Salomaa E.R., Tangrea J.A., Teppo L., Askin F.B., Taskinen E., Erozan Y., Greenwald P., Huttunen J.K. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 88:1996;1560-1570.
28. Rautalahti M.T., Virtamo J.R., Taylor P.R., Heinonen O.P., Albanes D., Haukka J.K., Edwards B.K., Karkkainen P.A., Stolzenberg-Solomon R.Z., Huttunen J. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer. 86:1999;37-42.
29. Omenn G.S., Goodman G., Thornquist M., Grizzle J., Rosenstock L., Barnhart S., Balmes J., Cherniack M.G., Cullen M.R., Glass A. The Beta-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res. Suppl. 54:1994;2038-2043.
30. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., Hammar S. Effects of a combination of beta-carotene and Vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1996;1150-1155.
31. Wang X.D., Russell R.M. Procarcinogenic and anticarcinogenic effects of beta-carotene. Nutr. Rev. 57:1999;263-272.
32. Okai Y., Higashi-Okai K., Yano Y., Otani S. All-trans beta-carotene enhances mitogenic responses and ornithine decarboxylase activity of BALB/c 3T3 fibroblast cells induced by tumor promoter and fetal bovine serum but suppresses mutagen-dependent umu C gene expression in Salmonella typhimurium (TA 1535/pSK 1002). Cancer Lett. 99:1996;15-21.
33. Mooney L.A., Bell D.A., Santella R.M., Van Bennekum A.M., Ottman R., Paik M., Blaner W.S., Lucier G.W., Covey L., Young T.L., Cooper T.B., Glassman A.H., Perera F.P. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis. 18:1997;503-509.
34. Badr F.M., El-Habit O.H., Hamdy M., Hassan G.A. The mutagenic versus protective role of Vitamin A on the induction of chromosomal aberration in human lymphocyte cultures. Mut. Res. 414:1998;157-163.
35. Leo M.A., Lieber C.S. Alcohol, Vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenesis. Am. J. Clin. Nutr. 69:1999;1071-1085.
36. Alam B.S., Alam S.Q., Weir J.C. Effects of excess Vitamin A and canthaxanthin on salivary gland tumors. Nutr. Cancer. 11:1988;233-241.
37. Hasegawa R., Takahashi M., Furukawa F., Toyoda K., Sato H., Hayashi Y. Co-carcinogenic effect of retinyl acetate on forestomach carcinogenesis of male F344 rats induced with butylated hydroxyanisole. Jpn. J. Cancer Res. 79:1988;320-328.
38. Goodman G.E., Metch B.J., Omenn G.S. The effect of long-term beta-carotene and Vitamin A administration on serum concentrations on alpha-tocopherol. Cancer Epidemiol. Biomarkers Prev. 3:1994;429-432.
39. Palozza P., Calviello G., Bartoli G.M. Prooxidant activity of beta-carotene under 100% oxygen pressure in rat liver microsomes. Free Rad. Biol. Med. 19:1995;887-892.
40. Mayne S.T., Handelman G.J., Beecher G. Beta-carotene and lung cancer promotion in heavy smokers - a plausible relationship. J. Natl. Cancer Inst. 88:1996;1513-1515.
41. Lotan R. Lung cancer promotion by beta-carotene and tobacco smoke: relationship to suppression of retinoic acid receptor-β and increased activator protein-1. J. Natl. Cancer Inst. 91:1999;7-9.
42. Wang X.D., Liu C., Bronson R.T., Smith D.E., Krinsky N.I., Russel M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J. Natl. Cancer Inst. 91:1999;60-66.
43. Paolini M., Cantelli-Forti G., Perocco P., Pedulli G.F., Abdel-Rahman S.Z., Legator M.S. Co-carcinogenic effect of beta-carotene. Nature. 398:1999;760-761.
44. Nitta Y., Kamiya K., Tanimoto M., Sadamoto S., Niwa O., Yokoro K. Induction of transplantable tumors by repeated subcutaneous injections of natural tumors by repeated subcutaneous injections of natural and synthetic Vitamin E in mice and rats. Jpn. J. Cancer Res. 82:1991;511-512.
45. McIntosh G.H. The influence of dietary Vitamin E and calcium status on intestinal tumors in rats. Nutr. Cancer. 17:1992;47-55.
46. Mitchel R.E.J., McCann R. Vitamin E is a complete tumor promoter in mouse skin. Carcinogenesis. 14:1993;659-662.
47. Lhuillery C., Cognault S., Germain E., Jourdan M.L., Bougnoux P. Suppression of the promoter effect of polyunsaturated fatty acids by the absence of dietary Vitamin E in experimental mammary carcinoma. Cancer Lett. 114:1997;233-234.
48. Chan S.W., Reade P.C. The role of ascorbic acid in oral cancer and carcinogenesis. Oral Dis. 4:1998;120-129.
49. Shibata M.A., Hirose M., Kagawa M., Boonyaphiphat P., Ito N. Enhancing effect of concomitant L-ascorbic acid administration on BHA-induced forestomach carcinogenesis in rats. Carcinogenesis. 14:1993;275-280.
50. King T.M., Trizna Z., Wu X., Amos C.I., Fueger J.J., Fritsche H.A., Hsu T.C., Winn R., Spitz M.R. A clinical trial to evaluate the effect of Vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas, M.D. Anderson Clinical Community Oncology Program Network. Cancer Epidemiol. Biomarkers Prev. 6:1997;537-542.
51. 3 promotion of rat urinary bladder carcinogenesis. Toxicol. Pathol. 25:1997;284-290.
52. Chen T.X., Wanibuchi H., Wei M., Morimura K., Yamamoto S., Hayashi S., Fukushima S. Concentration dependent promoting effects of sodium L-ascorbate with the same total dose in a rat two-stage urinary bladder carcinogenesis. Cancer Lett. 146:1999;67-71.
53. Schwartz J., Shklar G., Trickler D. Vitamin C enhances the development of carcinomas in the hamster buccal pouch experimental model. Oral Surg. Oral Med. Oral Pathol. 76:1993;718-722.
54. Podmore I.D., Griffiths H.R., Herbert K.E., Mistr N., Mistry P., Lunec J. Does Vitamin C have a pro-oxidant effects. Nature. 395:1998;231-232.
55. Blot W.J. Vitamin/mineral supplementation and cancer risk: international chemoprevention trials. Proc. Soc. Exp. Biol. Med. 216:1997;291-296.
56. Wattenberg L.W., Loub W.D. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res. 38:1978;1410-1413.
57. Tanaka T., Mori Y., Morishita Y., Hara A., Ohno T., Kojima T., Mori H. Inhibitory effects of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis. 11:1990;1403-1406.
58. Kim D.J., Lee K.K., Ahn B., Han B.S., Bae J.H., Jang J.J. Biphasic modifying effects of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form positive liver cell foci in Sprague-Dawley rats. Jpn. J. Cancer Res. 85:1994;578-583.
59. Oganesian A., Hendricks J.D., Williams D.E. Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model. Cancer Lett. 118:1997;87-94.
60. Morse M.A., La Greca S.D., Amin S.G., Chung F.L. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and deposition of NNK in A/J mice. Cancer Res. 50:1990;2613-2617.
61. Stoner G.D., Adam-Rodwell G., Morse M.A. Lung tumors in strain A mice: application for studies in cancer chemoprevention. J. Cell. Biochem. Suppl. 17:1993;95-103.
62. Chung F.L., Morse M.A., Eklind K.I., Xu Y. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea. Ann. N.Y. Acad. Sci. 686:1993;186-201.
63. El-Bayoumy K., Upadhyaya P., Desai D., Amin S., Hoffman D., Wynder E.L. Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethylisothiocyanate, indole-3-carbinol and d-limonene individually and in combination on the tumorigenicity of tobacco-specific nitrosamine 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res. 16:1996;2709-2712.
64. Bresnick E., Birt D.F., Wolterman K., Wheeler M., Markin R.S. Reduction in mammary tumorigenesis in the rat by cabbage and cabbage residue. Carcinogenesis. 11:1990;1159-1163.
65. Bradlow H.L., Michnovicz J., Telang N.T., Osborne M.P. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis. 12:1991;1571-1574.
66. Grubbs C.J., Steele V.E., Casebolt T., Juliana M.M., Eto I., Whitaker L.M., Dragnev K.H., Kelloff G.J., Lubet R.L. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res. 15:1995;709-716.
67. Niwa T., Swaneck G., Bradlow H.L. Alteration in estradiol metabolism in MFC-7 cells induced by treatment with indole-3-carbinol and related compounds. Steroids. 59:1994;523-527.
68. 3H )-methyltrienolone. Inhibition of steroid binding activity by the anticarcinogen indole-3-carbinol Biochem. J. 288:1992;361-367.
69. Arnao M.B., Sanchez-Bravo J., Acosta M. Indole-3-carbinol as a scavenger of free radicals. Biochem. Mol. Biol. Int. 39:1996;1125-1134.
70. Christensen J.G., Le Blanc G.A. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol. Cancer Res. 56:1996;574-581.
71. Baldwin W.S., LeBlanc G.A. The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice. Chem. Biol. Interact. 83:1992;155-169.
72. Pence B.C., Buddingh F., Yang S.P. Multiple dietary factors in enhancement of dimethylhydrazine carcinogenesis: main effect of indole-3-carbinol. J. Natl. Cancer Inst. 77:1986;269-276.
73. Bailey G.S., Hendricks J.D., Shelton D.W., Nixon J.E., Pawlowski N.E. Enhancement of carcinogenesis by natural anticarcinogen indole-3-carbinol. J. Natl. Cancer Inst. 78:1987;931-934.
74. Temple N.J., El-Khatib S. Cabbage and Vitamin E: their effect on colon tumor formation in mice. Cancer Lett. 35:1987;71-77.
75. Kim D.J., Han B.S., Ahn B., Hasegawa R., Shirai T., Ito N., Tsuda H. Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multiorgan carcinogenesis model. Carcinogenesis. 18:1997;377-381.
76. Birt D.F., Pelling J.C., Pour P.M., Tibbels M.G., Schweickert L., Bresnick E. Enhanced pancreatic and skin tumorigenesis in cabbage-fed hamsters and mice. Carcinogenesis. 8:1987;197-913.
77. 1-initiated hepatocarcinogenesis: results from a 9000 animal tumor study. Carcinogenesis. 20:1999;453-458.
78. Modly C.E., Das M., Don P.S., Marcelo C.S., Mukhtar H., Bickers D.R. Capsaicin as an in vitro inhibitor of benzo[a]pyrene metabolism and its DNA binding in human and murine keratinocytes. Drug Metab. Dipos. 14:1986;413-416.
79. Teel R.W. Effects of capsaicin on rat liver S9-mediated metabolism and DNA binding of aflatoxin. Nutr. Cancer. 15:1991;27-32.
80. Zhang Z., Hamilton S.M., Stewart C., Strother A., Teel R.W. Inhibition of liver microsomal cytochrome P-450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 13:1993;2341-2346.
81. Teel R.W., Zhang Z., Huynh H., Hamilton S.M. Effects of capsaicin on the metabolic activation of heterocyclic amines and on cytochrome P450 1A2 activity in hamster liver microsomes. Proc. Am. Assoc. Cancer Res. 38:1997;363.
82. Surh Y.J., Lee R.C., Park K.K., Mayne S.T., Liem A., Miller J.A. Chemopreventive effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine. Carcinogenesis. 16:1995;2467-2471.
83. Morre D.J., Chueh P.J., Morre D.M. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc. Natl. Acad. Sci. 92:1995;1831-1835.
84. Buiatti E., Palli D., Decarli A., Amadori D., Avellini C., Bianchi S., Biserni R., Cipriani F., Cocco P., Giacosa A. A case-control study of gastric cancer and diet in Italy. Int. J. Cancer. 44:1989;611-616.
85. Lopez-Carrillo L., Hernandez A.M., Dubrow R. Chili pepper consumption and gastric cancer in Mexico: a case control study. Am. J. Epidemiol. 139:1994;263-271.
86. Hoch-Ligeti C. Naturally occurring dietary agents and their role in production of tumors. Tex. Rep. Biol. Med. 10:1952;996-1005.
87. Toth B., Gannett P. Carcinogenicity of lifelong administration of capsaicin of hot pepper in mice. In Vivo. 6:1992;59-63.
88. Toth B., Rogan E., Walker B. Tumorigenicity and mutagenicity studies with capsaicin of hot peppers. Anticancer Res. 4:1984;117-119.
89. Agrawal R.C., Wiessler M., Hecker E., Bhide S.V. Tumour promoting effects of chili extracts in BALB/c mice. Int. J. Cancer. 38:1986;689-695.
90. Surh Y.J., Lee S.S. Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci. 56:1995;1845-1855.
91. Stroll A., Seeback E. Chemical investigations of Alliin, the specific principles of garlic. Adv. Enzymol. 11:1951;377-400.
92. Cavallito C.J., Buck J.S., Suter C.M. Allicin, the antibacterial principle of Allium sativum. Part II. Determination of the chemical structures. J. Am. Chem. Soc. 66:1944;1952-1954.
93. Moore G.S., Atkins R.D. The fungicidal and fungistatic effect of an aqueous garlic extract on medically important yeast like fungi. Mycologia. 69:1977;341-348.
94. Belman S. Onion and garlic oils inhibit tumor promotion. Carcinogenesis. 4:1983;1063-1065.
95. Wargovich M.J. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethyl-hydrazine-induced colon cancer. Carcinogenesis. 8:1987;487-489.
96. Kwak M.K., Kim S.G., Kwak J.Y., Novak R.F., Kim N.D. Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide allylmercaptan and allylmethylsulfide in rats. Biochem. Pharmacol. 47:1994;531.
97. Singh S.V., Pan S.S., Srivastava S.K., Xia H., Hu X., Zaren H.A., Orchard J.L. Differential induction of NAD(P)H: quinone oxidoreductase by anti-carcinogenic organosulfides from garlic. Biochem. Biophys. Res. Commun. 244:1998;917-920.
98. DiPaoloand J.A., Carruthers C. The effects of allicin from garlic on tumor growth. Cancer Res. 20:1960;431.
99. Takeyama H., Hoon D.S., Morton D.L., Irie F.R. Growth inhibition and modulation of cell markers of melanoma by an aged garlic product, sulfur-allyl cysteine. Proc. Am. Assoc. Cancer Res. 32:1991;426.
100. Takeyama H., Hoon H.D.S., Saxton R.E., Morton D.L., Irie R.F. Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteine. Oncology. 50:1993;63-69.
101. You W.C., Blot W.J., Chang Y.S., Ershow A., Yang Z.T., An Q., Henderson B.E. Jr., Fraumeni J.F., Wang T.G. Allium vegetables and reduced risk of stomach cancer. J. Natl. Cancer Inst. 81:1989;162-164.
102. Steinmetz K.A., Kushi L.H., Bostick R.M., Folsom A.R., Potter J.D. Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. Am. J. Epidemiol. 139:1994;1-15.
103. Dorant E., van den Brandt P.A., Goldbohm R.A., Hermus R.J.J., Sturmans F. Garlic and its significance for the prevention of cancer in humans: a critical review. Br. J. Cancer. 6:1993;424-429.
104. Dorant E., van den Brandt P.A., Goldbohm R.A. A prospective cohort study on Allium vegetable consumption, garlic supplement use, and the risk of lung carcinoma in the Netherlands. Cancer Res. 54:1994;6148-6153.
105. Dorant E., van den Brandt E.P.A., Goldbohm R.A. A prospective cohort study on the relationship between onion and leek consumption garlic supplement use and the risk of colorectal carcinoma in the Netherlands. Carcinogenesis. 17:1996;477-484.
106. Takahashi S., Hakoi K., Yada H., Hirose M., Ito N., Fukushima S. Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. Carcinogenesis. 13:1992;1513-1518.
107. Takada N., Kitano M., Chen T., Yano Y., Otani S., Fukushima S. Enhancing effects of organosulfur compounds from garlic and onions on hepatocarcinogenesis in rats: association with increased cell proliferation and elevated ornithine decarboxylase activity. Jpn. J. Cancer Res. 85:1994;1067-1072.
108. Takada N., Matsuda T., Otoshi T., Yano Y., Otani S., Hasegawa T., Nakae D., Konishi Y., Fukushima S. Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. Cancer Res. 54:1994;2895-2899.
109. Lisk D.J., Thompson J. Selenium-enriched garlic inhibits the early stage but not the late stage of mammary carcinogenesis. Carcinogenesis. 17:1996;1979-1982.
110. Agarwal S.K., Singh S.S., Verma S., Kumar S. Antifungal activity of anthraquinone derivatives from Rheum emodi. J. Ethnopharmacol. 72:2000;43-46.
111. Kupchan S.M., Karim A. Tumor inhibitor, 114. Aloe emodin: antileukemic principle isolated from Rhamnus frangula L. Lloydia. 39:1976;223-224.
112. Pecere T., Gazzola M.V., Mucignat C., Parolin C., Vecchia F.D., Cavaggioni A., Basso G., Diaspro A., Salvato B., Carli M., Palu G. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res. 60:2000;2800-2804.
113. Su H.Y., Cherng S.H., Chen C.C., Lee H. Emodin inhibits the mutagenicity and DNA adduct induced by 1-nitropyrene. Mut. Res. 329:1995;205-212.
114. Hao N.J., Huang M.P., Lee H. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinone. Mut. Res. 328:1995;183-191.
115. Sakai R. Epidemiologic survey on lung cancer with respect to cigarette smoking and plant diet. Jpn. J. Cancer Res. 80:1989;155-159.
116. Winters W.D., Benavides R., Clouse W.J. Effects of aloe extracts on human normal and tumor cells in vitro. Eco. Bot. 35:1981;89-95.
117. Imanishi K., Ishiguro T., Saito H., Suzuki I. Pharmacological studies on a plant lectin, Aloctin A. Part I. Growth inhibition of mouse methylcholanthrene induced fibrosarcoma (Meth A) in ascites form by Aloctin A. Experientia. 37:1981;1186-1187.
118. Ishiguro T., Imanishi K., Suzuki T. Hemopexin levels in mice. Int. J. Immunopharmacol. 8:1984;855-858.
119. Yoshimoto R., Kondoh N., Isawa M., Hamuro J. Plant lectin, ATF1011, on the tumor cell surface augments tumor-specific immunity through activation of T cells specific for the lectin. Cancer Immunol. Immunother. 25:1987;25-30.
120. Yagi A., Makino K., Nishioka I., Kuchino Y. Aloe mannan, polysaccharide from Aloe arborescens var. natalensis. Plant Med. 31:1977;17-20.
121. Ralamboranto L., Rakotovao L.H., Le Deaut J.Y., Chaussoux D., Salomon J.C., Fournet B., Montreuil J., Rakotonirina-Randriambeloma P.J., Dulat C., Coulanges P. Immunomodulating properties of an extract isolated and partially purified from Aloe vahombe. Study of antitumoral properties and contribution to the chemical nature and active principle. Arch. Inst. Pasteur. Madagascar. 50:1982;227-256.
122. Kim H.S., Kacew S., Lee B.M. In vitro chemopreventive effects of plant polysaccharides (Aloe barbidensis miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis. 20:1999;1637-1640.
123. Westendorf J., Marquardt H., Poginsky B., Dominiak M., Schmidt J., Marquardt H. Genotoxicity of naturally occurring hydroxyanthraquinones. Mut. Res. 240:1990;1-12.
124. Strickland F.M., Muller H.K., Stephens L.C., Bucana C.D., Donawho C.K., Sun Y., Pelley R.P. Induction of primary cutaneous melanomas in C3H mice by combined treatment with ultraviolet radiation, ethanol and aloe emodin. Photochem. Photobiol. 72:2000;407-414.
125. Wolfle D., Schmutte C., Westendorf J., Marquardt H. Hydroxyanthraquinones as tumor promoters: enhancement of malignant transformation of C3H mouse fibroblasts and growth stimulation of primary rat hepatocytes. Cancer Res. 50:1990;6540-6544.
126. Mueller S.O., Stopper H. Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim. Biophys. Acta. 1428:1999;406-414.
127. Mueller S.O., Stopper S.O.H., Dekant W. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites. Drug Metab. Dispos. 26:1998;540-546.
128. Halliwell B., A Murcia M., Chirico S., Aruoma O.I. Free radicals and antioxidants in food and in vivo: what they do and how they work. Crit. Rev. Food Sci. Nutr. 35:1995;7-20.
129. Diplock A.T., Rice-Evans C.A., Burdon R.H. Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention. Cancer Res. Suppl. 54:1994;1952-1956.
130. Oikawa S., Yamada K., Yamashita N., Tada-Oikawa S., Kawanishi S. N-acetylcysteine, a cancer chemopreventive agent, causes oxidative damage to cellular and isolated DNA. Carcinogenesis. 20:1999;1485-1490.
131. Kim H.S., Lee B.M. Inhibition of benzo[a]pyrene-DNA adduct formation by Aloe barbadensis Miller. Carcinogenesis. 18:1997;771-776.
132. Lee M.J., Lee O.H., Yoon S.H., Lee S.K., Chung M.H., Park Y.I., Sung C.K., Choi J.S., Kim K.W. In vitro angiogenic activity of Aloe vera gel on calf pulmonary artery endothelial (CPAE) cell. Arch. Pharm. Res. 21:1998;260-265.
133. Paolini M., Mesirca R., Pozzetti L., Gialluca N., Bauer C., Biagi G.L., Cantelli-Forti G. Cancer chemoprevention: some complications and limitations. Cancer Detect. Prev. 22:1998;68-74.
134. Ames B.N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science. 221:1983;1256-1264.
135. Tsuda H., Ito M., Hirono I., Kawai K., Beppu H., Fujita K., Nagao M. Inhibitory effect of Aloe arborescens Miller. var. natalensis Berger (Kidachi aloe) on induction of preneoplastic focal lesions in the rat liver. Phytother. Res. Suppl. 7:1993;43-47.
136. Richeux F., Cascante M., Ennamany R., Sabourneau D., Creppy E.E. Cytotoxicity and genotoxicity of capsaicin in human neuroblastroma cells SHSY-5Y. Arch. Toxicol. 73:1999;403-409.
137. Schorkhuber M., Richter M., Dutter A., Sontag G., Marian B. BEffects of anthraquinone-laxatives on the proliferation and urokinase secretion of normal, premalignant and malignant colonic epithelial cells. Eur. J. Cancer. 43:1998;1091-1098.